Utah Medical Products, Inc. (UTMD) Earnings History
Annual and quarterly earnings data from 1989 to 2025
Loading earnings history...
UTMD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
UTMD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 51.6% | 29.6% | 29.3% |
| 2024 | 59.0% | 33.2% | 33.9% |
| 2023 | 59.8% | 33.4% | 33.1% |
| 2022 | 61.6% | 37.9% | 31.5% |
| 2021 | 63.0% | 38.5% | 30.1% |
Download Data
Export UTMD earnings history in CSV or JSON format
Free sign-in required to download data
Utah Medical Products, Inc. (UTMD) Earnings Overview
As of May 8, 2026, Utah Medical Products, Inc. (UTMD) reported trailing twelve-month net income of $11M, reflecting -12.1% year-over-year growth. The company earned $3.53 per diluted share over the past four quarters, with a net profit margin of 29.3%.
Looking at the long-term picture, UTMD's 5-year EPS compound annual growth rate (CAGR) stands at +3.4%, reflecting modest earnings expansion. The company achieved its highest annual net income of $21M in fiscal 2003.
Utah Medical Products, Inc. maintains industry-leading profitability with a gross margin of 51.6%, operating margin of 29.6%, and net margin of 29.3%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including NVCR (-$173M net income, -20.8% margin), MMSI ($139M net income, 8.5% margin), LMAT ($62M net income, 23.1% margin), UTMD has outperformed on profitability metrics. Compare UTMD vs NVCR →
UTMD Earnings vs Peers
Earnings metrics vs comparable public companies
UTMD Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $11M | -18.7% | $11M | $3.48 | 29.3% | 29.6% |
| 2024 | $14M | -16.6% | $14M | $3.96 | 33.9% | 33.2% |
| 2023 | $17M | +1.0% | $17M | $4.57 | 33.1% | 33.4% |
| 2022 | $16M | +11.4% | $20M | $4.52 | 31.5% | 37.9% |
| 2021 | $15M | +37.0% | $19M | $4.04 | 30.1% | 38.5% |
| 2020 | $11M | -26.7% | $14M | $2.94 | 25.6% | 32.5% |
| 2019 | $15M | -20.6% | $18M | $3.94 | 31.4% | 37.6% |
| 2018 | $19M | +118.2% | $19M | $4.95 | 44.2% | 44.5% |
| 2017 | $9M | -29.9% | $19M | $2.28 | 20.5% | 45.9% |
| 2016 | $12M | +2.4% | $16M | $3.22 | 30.9% | 41.2% |
See UTMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs UTMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare UTMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonUTMD — Frequently Asked Questions
Quick answers to the most common questions about buying UTMD stock.
Is UTMD growing earnings?
UTMD EPS fell to $3.53, with earnings declining -12.1%. This contrasts with the 5-year CAGR of +3.4%. TTM net income dropped to $11M.
What are UTMD's profit margins?
Utah Medical Products, Inc. net margin is +29.3%, with operating margin at +29.6%. Above-average margins indicate pricing power.
How consistent are UTMD's earnings?
UTMD earnings data spans 1989-2025. The declining earnings trend is -12.1% YoY. Historical data enables comparison across business cycles.